E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/14/2024 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley sells $500,000 14.25% callable contingent income securities on ETFs

Chicago, Feb. 14 – Morgan Stanley Finance LLC priced $500,000 of callable contingent income securities due Dec. 31, 2026 linked to the worst performing of the SPDR S&P Biotech ETF, Energy Select Sector SPDR Fund and Utilities Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 14.25%, paid monthly, if each underlying fund closes at or above its 70% coupon barrier on the related monthly observation date.

The securities may be called starting April 2, 2024 at par on any quarterly call date.

At maturity the payout will be par unless the worst performing fund closes below its 60% downside threshold in which case investors will be fully exposed to the decline of the worst performing fund.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Callable contingent income securities
Underlying ETFs:SPDR S&P Biotech ETF, Energy Select Sector SPDR Fund and Utilities Select Sector SPDR Fund
Amount:$500,000
Maturity:Dec. 31, 2026
Coupon:14.25% annual rate, paid monthly, if each underlying fund closes at or above its 70% coupon barrier on the related monthly observation date
Price:Par
Payout at maturity:Par unless the worst performing fund closes below its downside threshold level in which case investors will be fully exposed to the decline in the worst performing underlying fund
Call:Starting April 2, 2024 at par on any quarterly call date
Initial levels:$90.86 for biotech, $84.03 for energy, $63.41 for utilities
Coupon barriers:$63.602 for biotech, $58.821 for energy, $44.387 for utilities, 70% of initial levels
Downside thresholds:$54.516 for biotech, $50.418 for energy, $38.046 for utilities, 60% of initial levels
Pricing date:Dec. 28, 2023
Settlement date:Jan. 3, 2024
Agent:Morgan Stanley & Co. LLC
Fees:0.25%
Cusip:61771WEN4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.